Vericel Corp [VCEL] stock is trading at $58.67, down -1.59%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VCEL shares have gain 1.84% over the last week, with a monthly amount glided 1.29%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vericel Corp [NASDAQ: VCEL] stock has seen the most recent analyst activity on August 09, 2024, when Canaccord Genuity initiated its Buy rating and assigned the stock a price target of $57. Previously, TD Cowen started tracking the stock with Buy rating on June 20, 2024, and set its price target to $55. On January 25, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $51 on the stock. BTIG Research upgraded its rating to a Buy but stick to its price target of $39 on August 08, 2023. BTIG Research downgraded its rating to a Neutral. Truist downgraded its rating to Hold for this stock on November 09, 2022.
Vericel Corp [VCEL] stock has fluctuated between $37.35 and $61.49 over the past year. Currently, Wall Street analysts expect the stock to reach $60.67 within the next 12 months. Vericel Corp [NASDAQ: VCEL] shares were valued at $58.67 at the most recent close of the market. An investor can expect a potential return of 3.41% based on the average VCEL price forecast.
Analyzing the VCEL fundamentals
Vericel Corp [NASDAQ:VCEL] reported sales of 226.84M for the trailing twelve months, which represents a growth of 27.04%. Gross Profit Margin for this corporation currently stands at 0.71% with Operating Profit Margin at -0.01%, Pretax Profit Margin comes in at 0.02%, and Net Profit Margin reading is 0.02%. To continue investigating profitability, this company’s Return on Assets is posted at 0.01, Equity is 0.01 and Total Capital is -0.0. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.38.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 56.61 points at the first support level, and at 54.55 for the second support level. However, for the 1st resistance point, the stock is sitting at 60.83, and for the 2nd resistance point, it is at 62.99.
Ratios To Look Out For
For context, Vericel Corp’s Current Ratio is 4.61. In addition, the Quick Ratio stands at 4.23 and the Cash Ratio stands at 1.3. Considering the valuation of this stock, the price to sales ratio is 12.77, the price to book ratio is 11.23 and price to earnings (TTM) ratio is 938.72.
Transactions by insiders
Recent insider trading involved Wotton Paul K, Director, that happened on Dec 04 ’24 when 2600.0 shares were sold. Director, Wotton Paul K completed a deal on Dec 04 ’24 to buy 2600.0 shares. Meanwhile, Chief Medical Officer Hopper Jonathan Mark sold 10000.0 shares on Dec 02 ’24.
